Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1981 Jan;31(1):297–308. doi: 10.1128/iai.31.1.297-308.1981

Mouse model for abortive rabies infection of the central nervous system.

J S Smith
PMCID: PMC351782  PMID: 6163717

Abstract

When adult mice were injected by the footpad route with the attenuated rabies virus ERA/BHK, serum- and brain-associated antibody and interferon were produced, nonspecific cytotoxic cells and virus-specific cytolytic T cells in the spleen were activated, and a nonlethal infection of the central nervous system occurred. Cyclophosphamide treatment of these animals 1 day after virus infection suppressed antibody formation and induction of cytolytic T cells and resulted in a lethal infection. Virus injection into athymic mice also produced lethal infections. This indicated the importance of the T-cell response in survival but did not allow the response of cytolytic T cells to be distinguished from that of helper T cells. because cyclophosphamide has a longer-lasting effect on B cells than on T cells, the resulting mortality when virus is injected at intervals after cyclophosphamide treatment can be used to distinguish the importance of each of these cells in viral clearance. Although delay of rabies virus ERA/BHK injection until 3 days after cyclophosphamide treatment resulted in induction of a strong cytolytic T-cell response and reduced mortality, the mortality could be further reduced by delaying virus infection until the B-cell response had recovered. This indicated that both humoral and cellular immune components were vital for survival in this model.

Full text

PDF
297

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abelseth M. K. An Attenuated Rabies Vaccine for Domestic Animals Produced in Tissue Culture. Can Vet J. 1964 Nov;5(11):279–286. [PMC free article] [PubMed] [Google Scholar]
  2. Arko R. J., Schneider L. G., Baer G. M. Nonfatal canine rabies. Am J Vet Res. 1973 Jul;34(7):937–938. [PubMed] [Google Scholar]
  3. Atanasiu P. Quantitative assay and potency test of antirabies serum and immunoglobulin. Monogr Ser World Health Organ. 1973;(23):314–318. [PubMed] [Google Scholar]
  4. BOLIN V. S. Survival of a guinea pig following infection with street rabies virus; a case report. J Am Vet Med Assoc. 1959 Jan 15;134(2):90–92. [PubMed] [Google Scholar]
  5. Baer G. M., Cleary W. F., Díaz A. M., Perl D. F. Characteristics of 11 rabies virus isolates in mice: titers and relative invasiveness of virus, incubation period of infection, and survival of mice with sequelae. J Infect Dis. 1977 Sep;136(3):336–345. doi: 10.1093/infdis/136.3.336. [DOI] [PubMed] [Google Scholar]
  6. Baer G. M., Olson H. R. Recovery of pigs from rabies. J Am Vet Med Assoc. 1972 Apr 15;160(8):1127–1128. [PubMed] [Google Scholar]
  7. Bell J. F., Lodmell D. L., Moore G. J., Raymond G. H. Brain neutralization of rabies virus to distinguish recovered animals from previously vaccinated animals. J Immunol. 1966 Dec;97(6):747–753. [PubMed] [Google Scholar]
  8. Blanden R. V. Mechanisms of recovery from a generalized viral infection: mousepox. 3. Regression infectious foci. J Exp Med. 1971 May 1;133(5):1090–1104. doi: 10.1084/jem.133.5.1090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Daniels C. A., Borsos T., Rapp H. J., Snyderman R., Notkins A. L. Neutralization of sensitized virus by purified components of complement. Proc Natl Acad Sci U S A. 1970 Mar;65(3):528–535. doi: 10.1073/pnas.65.3.528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ferris D. H., Badiali L., Abou-Youssef M., Beamer P. D. A note on experimental rabies in the donkey. Cornell Vet. 1968 Apr;58(2):270–277. [PubMed] [Google Scholar]
  11. Fischman H. R., Strandberg J. D. Inapparent rabies virus infection of the central nervous system. J Am Vet Med Assoc. 1973 Nov 1;163(9):1050–1055. [PubMed] [Google Scholar]
  12. Franklin E. C., Frangione B., Prelli F. The defect in mu heavy chain disease protein GLI. J Immunol. 1976 Apr;116(4):1194–1195. [PubMed] [Google Scholar]
  13. Hattwick M. A., Corey L., Creech W. B. Clinical use of human globulin immune to rabies virus. J Infect Dis. 1976 Jun;133 (Suppl):A266–A272. doi: 10.1093/infdis/133.supplement_2.a266. [DOI] [PubMed] [Google Scholar]
  14. Hattwick M. A., Weis T. T., Stechschulte C. J., Baer G. M., Gregg M. B. Recovery from rabies. A case report. Ann Intern Med. 1972 Jun;76(6):931–942. doi: 10.7326/0003-4819-76-6-931. [DOI] [PubMed] [Google Scholar]
  15. Held J. R., Tierkel E. S., Steele J. H. Rabies in man and animals in the United States, 1946-65. Public Health Rep. 1967 Nov;82(11):1009–1018. [PMC free article] [PubMed] [Google Scholar]
  16. Herberman R. B., Nunn M. E., Holden H. T., Staal S., Djeu J. Y. Augmentation of natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic target cells. Int J Cancer. 1977 Apr 15;19(4):555–564. doi: 10.1002/ijc.2910190417. [DOI] [PubMed] [Google Scholar]
  17. Heron I., Berg K., Cantell K. Regulatory effect of interferon on T cells in vitro. J Immunol. 1976 Oct;117(4):1370–1373. [PubMed] [Google Scholar]
  18. Hirsch R. L., Griffin D. E., Johnson R. T. Interactions between immune cells and antibody in protection from fatal Sindbis virus encephalitis. Infect Immun. 1979 Feb;23(2):320–324. doi: 10.1128/iai.23.2.320-324.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Iwasaki Y., Clark H. F. Cell to cell transmission of virus in the central nervous system. II. Experimental rabies in mouse. Lab Invest. 1975 Oct;33(4):391–399. [PubMed] [Google Scholar]
  20. Iwasaki Y., Gerhard W., Clark H. F. Role of host immune response in the development of either encephalitic or paralytic disease after experimental rabies infection in mice. Infect Immun. 1977 Oct;18(1):220–225. doi: 10.1128/iai.18.1.220-225.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. KITSELMAN C. H. RECOVERY OF A RAT FROM EXPERIMENTALLY INDUCED RABIES. J Am Vet Med Assoc. 1964 May 15;144:1113–1114. [PubMed] [Google Scholar]
  22. Kanra G. Y., Vesikari T. Cytotoxic activity against rubella-infected cells in the supernatants of human lymphocyte cultures stimulated by rubella virus. Clin Exp Immunol. 1975 Jan;19(1):17–32. [PMC free article] [PubMed] [Google Scholar]
  23. Lagrange P. H., Mackaness G. B., Miller T. E. Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide. J Exp Med. 1974 Jun 1;139(6):1529–1539. doi: 10.1084/jem.139.6.1529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Marbrook J., Baguley B. C. The recovery of immune responsiveness after treatment with cyclophosphamide. Int Arch Allergy Appl Immunol. 1971;41(6):802–812. doi: 10.1159/000230572. [DOI] [PubMed] [Google Scholar]
  25. McLaren C., Potter C. W. The relationship between interferon and virus virulence in influenza virus infections of the mouse. J Med Microbiol. 1973 Feb;6(1):21–32. doi: 10.1099/00222615-6-1-21. [DOI] [PubMed] [Google Scholar]
  26. Miller A., Morse H. C., 3rd, Winkelstein J., Nathanson N. The role of antibody in recovery from experimental rabies. I. Effect of depletion of B and T cells. J Immunol. 1978 Jul;121(1):321–326. [PubMed] [Google Scholar]
  27. Murphy F. A., Bauer S. P. Early street rabies virus infection in striated muscle and later progression to the central nervous system. Intervirology. 1974;3(4):256–268. doi: 10.1159/000149762. [DOI] [PubMed] [Google Scholar]
  28. Murphy F. A. Rabies pathogenesis. Arch Virol. 1977;54(4):279–297. doi: 10.1007/BF01314774. [DOI] [PubMed] [Google Scholar]
  29. Nathanson N., Cole G. A. Immunosuppression and experimental virus infection of the nervous system. Adv Virus Res. 1970;16:397–448. doi: 10.1016/S0065-3527(08)60028-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Porras C., Barboza J. J., Fuenzalida E., Adaros H. L., Oviedo A. M., Furst J. Recovery from rabies in man. Ann Intern Med. 1976 Jul;85(1):44–48. doi: 10.7326/0003-4819-85-1-44. [DOI] [PubMed] [Google Scholar]
  31. Quinnan G. V., Manischewitz J. E. The role of natural killer cells and antibody-dependent cell-mediated cytotoxicity during murine cytomegalovirus infection. J Exp Med. 1979 Dec 1;150(6):1549–1554. doi: 10.1084/jem.150.6.1549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Sedwick W. D., Wiktor T. J. Reproducible plaquing system for rabies, lymphocytic choriomeningitis,k and other ribonucleic acid viruses in BHK-21-13S agarose suspensions. J Virol. 1967 Dec;1(6):1224–1226. doi: 10.1128/jvi.1.6.1224-1226.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Smith J. S., Yager P. A., Baer G. M. A rapid reproducible test for determining rabies neutralizing antibody. Bull World Health Organ. 1973 May;48(5):535–541. [PMC free article] [PubMed] [Google Scholar]
  34. Stewart W. E., 2nd, Sulkin S. E. Interferon production in hamsters experimentally infected with rabies virus. Proc Soc Exp Biol Med. 1966 Dec;123(3):650–654. doi: 10.3181/00379727-123-31568. [DOI] [PubMed] [Google Scholar]
  35. Stockman G. D., Heim L. R., South M. A., Trentin J. J. Differential effects of cyclophosphamide on the B and T cell compartments of adult mice. J Immunol. 1973 Jan;110(1):277–282. [PubMed] [Google Scholar]
  36. Sullivan J. L., Mayner R. E., Barry D. W., Ennis F. A. Influenza virus infection in nude mice. J Infect Dis. 1976 Jan;133(1):91–94. doi: 10.1093/infdis/133.1.91. [DOI] [PubMed] [Google Scholar]
  37. Turk J. L. Evidence for a preferential effect of cyclophosphamide on B-cells. Proc R Soc Med. 1973 Aug;66(8):805–808. doi: 10.1177/003591577306600837. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Turk J. L., Poulter L. W. Selective depletion of lymphoid tissue by cyclophosphamide. Clin Exp Immunol. 1972 Feb;10(2):285–296. [PMC free article] [PubMed] [Google Scholar]
  39. Turner G. S. Recovery of immune responsiveness to rabies vaccine after treatment of mice with cyclophosphamide. Arch Virol. 1979;61(4):321–325. doi: 10.1007/BF01315019. [DOI] [PubMed] [Google Scholar]
  40. Turner G. S. Thymus dependence of rabies vaccine. J Gen Virol. 1976 Dec;33(3):535–538. doi: 10.1099/0022-1317-33-3-535. [DOI] [PubMed] [Google Scholar]
  41. WAGNER R. R. Biological studies of interferon. I. Suppression of cellular infection with eastern equine encephalomyelitis virus. Virology. 1961 Mar;13:323–337. doi: 10.1016/0042-6822(61)90152-0. [DOI] [PubMed] [Google Scholar]
  42. Welsh R. M., Jr Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. I. Characterization of natural killer cell induction. J Exp Med. 1978 Jul 1;148(1):163–181. doi: 10.1084/jem.148.1.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Wiktor T. J., Doherty P. C., Koprowski H. In vitro evidence of cell-mediated immunity after exposure of mice to both live and inactivated rabies virus. Proc Natl Acad Sci U S A. 1977 Jan;74(1):334–338. doi: 10.1073/pnas.74.1.334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Wiktor T. J., Doherty P. C., Koprowski H. Suppression of cell-mediated immunity by street rabies virus. J Exp Med. 1977 Jun 1;145(6):1617–1622. doi: 10.1084/jem.145.6.1617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Wiktor T. J., Koprowski H., Rorke L. B. Localized rabies infection in mice. Proc Soc Exp Biol Med. 1972 Jul;140(3):759–764. doi: 10.3181/00379727-140-36547. [DOI] [PubMed] [Google Scholar]
  46. Wilsnack R. E., Parker R. L. Pathogenesis of skunk rabies virus: rabies inhibiting substance as related to rabies diagnosis. Am J Vet Res. 1966 Jan;27(116):39–43. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES